Leão Pereira Pinto Selected Research

Leão Pereira Pinto Research Topics

Disease

20	Neoplasms (Cancer) 09/2022 - 01/2005
8	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018 - 01/2003
4	Odontogenic Cysts (Keratocyst) 09/2022 - 04/2002
4	Pleomorphic Adenoma 01/2021 - 06/2006
4	Neoplasm Metastasis (Metastasis) 09/2015 - 01/2009
3	Squamous Cell Carcinoma of Head and Neck 01/2022 - 02/2009
3	Adenoid Cystic Carcinoma (Cylindroma) 01/2021 - 01/2017
3	Carcinoma (Carcinomatosis) 02/2009 - 01/2005
2	Carcinogenesis 12/2022 - 03/2013
2	Cysts 02/2018 - 04/2002
2	Hypoxia (Hypoxemia) 03/2016 - 09/2015
2	Stomatitis 01/2011 - 04/2003
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2011 - 04/2003
2	Radicular Cyst 12/2010 - 04/2002
1	Wounds and Injuries (Trauma) 06/2020
1	Hemorrhage 06/2020
1	Lymphatic Metastasis 10/2018
1	Granuloma 02/2018
1	Foreign-Body Reaction 10/2017
1	Mucoepidermoid Carcinoma 06/2017
1	Residual Neoplasm 03/2017
1	Gingivitis 03/2016
1	Periodontitis 03/2016
1	Periodontal Diseases (Periodontal Disease) 03/2016
1	Tongue Neoplasms (Tongue Neoplasm) 09/2015
1	Chronic Periodontitis 01/2015
1	Gingival Overgrowth 01/2015
1	Disease Progression 03/2013
1	Basal Cell Nevus Syndrome (Gorlin Syndrome) 03/2012
1	Bone Resorption 03/2012
1	Fibroma (Fibromatosis) 03/2011
1	Hyperplasia 03/2011
1	Leukemia 01/2011
1	Ameloblastoma 06/2007
1	Adenoameloblastoma 06/2007
1	Dentigerous Cyst 04/2002

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 12/2022 - 04/2002
5	Biological ProductsIBA 01/2022 - 06/2007
3	Glucose (Dextrose)FDA LinkGeneric 06/2017 - 09/2014
3	Cadherins (E-Cadherin)IBA 01/2017 - 01/2009
3	DNA (Deoxyribonucleic Acid)IBA 08/2011 - 09/2008
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 03/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2016 - 12/2010
2	IntegrinsIBA 03/2013 - 06/2007
2	Antineoplastic Agents (Antineoplastics)IBA 01/2011 - 04/2003
2	StreptavidinIBA 06/2006 - 04/2002
2	Biotin (Vitamin H)FDA Link 06/2006 - 04/2002
1	Capsules (Microcapsules)IBA 09/2022
1	Plasminogen Activator Inhibitor 1IBA 01/2022
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2022
1	Phenobarbital (Luminal)FDA Link 01/2021
1	1-dodecylpyridoxal (PLD)IBA 10/2018
1	CholesterolIBA 02/2018
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2018
1	Urokinase Plasminogen Activator ReceptorsIBA 01/2018
1	Keratins (Keratin)IBA 10/2017
1	Vascular Endothelial Growth Factor CIBA 12/2016
1	CytokinesIBA 03/2016
1	EndotoxinsIBA 03/2016
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 09/2015
1	Phenytoin (Dilantin)FDA LinkGeneric 01/2015
1	Aligeron (AS 2)IBA 12/2012
1	Claudin-1IBA 12/2012
1	RANK LigandIBA 03/2012
1	OsteoprotegerinIBA 03/2012
1	Tryptases (Tryptase)IBA 03/2011
1	CoagulaseIBA 01/2011
1	chlorhexidine gluconate (Dyna-Hex)FDA LinkGeneric 01/2011
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 12/2010
1	Bone Morphogenetic Protein ReceptorsIBA 07/2010
1	Type I Bone Morphogenetic Protein ReceptorsIBA 07/2010
1	Bone Morphogenetic Protein 2IBA 07/2010
1	beta CateninIBA 02/2009
1	Cell Cycle ProteinsIBA 09/2008
1	ParaffinIBA 06/2007
1	Integrin alpha5beta1IBA 06/2007
1	Fibronectins (Fibronectin)IBA 06/2006
1	TenascinIBA 06/2006
1	AntibodiesIBA 06/2006
1	Matrix Metalloproteinases (MMPs)IBA 01/2005
1	Metalloproteases (Metalloproteinases)IBA 01/2005
1	ChlorhexidineIBA 04/2003
1	MouthwashesIBA 04/2003
1	Indicators and Reagents (Reagents)IBA 01/2003
1	Collagen Type IV (Type IV Collagen)IBA 04/2002
1	Laminin (Merosin)IBA 04/2002

Therapy/Procedure

2	Oral Pathology 02/2018 - 08/2011
2	Drug Therapy (Chemotherapy) 03/2017 - 01/2011
2	Therapeutics 09/2015 - 01/2015
1	Prostheses and Implants (Prosthesis) 06/2020